Suppr超能文献

筛查效果研究中的未控制混杂:结肠镜检查的实例。

Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy.

机构信息

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.

出版信息

J Med Screen. 2013 Dec;20(4):198-207. doi: 10.1177/0969141313508282. Epub 2013 Oct 21.

Abstract

OBJECTIVE

To estimate the expected magnitude of error produced by uncontrolled confounding from health behaviours in observational medical record-based studies evaluating effectiveness of screening colonoscopy.

METHODS

We used data from the prospective National Institutes of Health American Association of Retired Persons (NIH-AARP) Diet and Health Study to assess the impact of health behaviour related factors (lifestyle, education, and use of non-steroidal anti-inflammatory drugs [NSAID]) on the association between colonoscopy and colorectal cancer (CRC) mortality. We first examined the difference between adjusted and unadjusted results within the cohort data, and then estimated a broader range of likely confounding errors based on the Breslow-Day approach that uses prevalence of confounders among persons with and without exposure, and the rate ratio reflecting the association between these confounders and the outcome of interest. As dietary factors and habits are often inter-correlated, we combined these variables (physical activity, body mass index, waist-to-hip ratio, alcohol consumption, and intakes of red meat, processed meat, fibre, milk, and calcium) into a "healthy lifestyle score" (HLS).

RESULTS

The estimated error (a ratio of biased-to-true result) attributable to confounding by HLS was 0.959-0.997, indicating less than 5% departure from the true effect of colonoscopy on CRC mortality. The corresponding errors ranged from 0.970 to 0.996 for NSAID, and from 0.974 to 1.006 for education (all ≤3% difference). The results for other CRC screening tests were similar.

CONCLUSION

Health behaviour-related confounders, either alone or in combination, seem unlikely to strongly affect the association between colonoscopy and CRC mortality in observational studies of CRC screening.

摘要

目的

评估在评估筛查结肠镜检查效果的基于观察性医疗记录的医学研究中,因健康行为不受控制而产生的误差幅度。

方法

我们使用前瞻性美国国立卫生研究院美国退休人员协会(NIH-AARP)饮食与健康研究的数据,评估与健康行为相关的因素(生活方式、教育和非甾体抗炎药(NSAID)的使用)对结肠镜检查与结直肠癌(CRC)死亡率之间关联的影响。我们首先在队列数据中检查了调整和未调整结果之间的差异,然后根据 Breslow-Day 方法估计了更广泛的可能混杂误差范围,该方法使用了暴露人群和非暴露人群中混杂因素的患病率,以及反映这些混杂因素与感兴趣结局之间关联的率比。由于饮食因素和习惯经常相互关联,我们将这些变量(身体活动、体重指数、腰臀比、饮酒量以及红肉、加工肉、纤维、牛奶和钙的摄入量)组合成一个“健康生活方式评分”(HLS)。

结果

归因于 HLS 混杂的估计误差(偏倚结果与真实结果的比值)为 0.959-0.997,表明结肠镜检查对 CRC 死亡率的真实影响偏差小于 5%。NSAID 的相应误差范围为 0.970 至 0.996,教育的相应误差范围为 0.974 至 1.006(均相差≤3%)。其他 CRC 筛查测试的结果也类似。

结论

在 CRC 筛查的观察性研究中,健康行为相关的混杂因素,无论是单独还是组合在一起,似乎不太可能强烈影响结肠镜检查与 CRC 死亡率之间的关联。

相似文献

1
Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy.
J Med Screen. 2013 Dec;20(4):198-207. doi: 10.1177/0969141313508282. Epub 2013 Oct 21.
2
3
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.
4
Colonoscopy and Colorectal Cancer Mortality in the Veterans Affairs Health Care System: A Case-Control Study.
Ann Intern Med. 2018 Apr 3;168(7):481-488. doi: 10.7326/M17-0723. Epub 2018 Mar 6.
5
Protection from colorectal cancer after colonoscopy: a population-based, case-control study.
Ann Intern Med. 2011 Jan 4;154(1):22-30. doi: 10.7326/0003-4819-154-1-201101040-00004.
7
Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.
8
Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
J Gen Intern Med. 2016 Oct;31(10):1190-7. doi: 10.1007/s11606-016-3760-9. Epub 2016 Jun 8.
9

引用本文的文献

1
Balancing early detection and over-screening: Evaluating colonoscopy's role in shaping colorectal cancer trends in Korea.
World J Gastrointest Oncol. 2025 Mar 15;17(3):102858. doi: 10.4251/wjgo.v17.i3.102858.
3
Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death.
JAMA Netw Open. 2024 Jul 1;7(7):e2423671. doi: 10.1001/jamanetworkopen.2024.23671.
5
Screening for Colorectal Cancer.
Hematol Oncol Clin North Am. 2022 Jun;36(3):393-414. doi: 10.1016/j.hoc.2022.02.001. Epub 2022 Apr 30.
7
The IARC Perspective on Colorectal Cancer Screening.
N Engl J Med. 2018 May 3;378(18):1734-1740. doi: 10.1056/NEJMsr1714643. Epub 2018 Mar 26.
9
Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis.
Am J Gastroenterol. 2016 Mar;111(3):355-65. doi: 10.1038/ajg.2015.418. Epub 2016 Jan 12.

本文引用的文献

1
Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
Am J Gastroenterol. 2017 Nov;112(11):1736-1746. doi: 10.1038/ajg.2017.286. Epub 2017 Oct 10.
2
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study.
Ann Intern Med. 2013 Mar 5;158(5 Pt 1):312-20. doi: 10.7326/0003-4819-158-5-201303050-00003.
3
The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer.
Endoscopy. 2012 Jul;44(7):695-702. doi: 10.1055/s-0032-1306895. Epub 2012 Jun 21.
4
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.
N Engl J Med. 2012 Jun 21;366(25):2345-57. doi: 10.1056/NEJMoa1114635. Epub 2012 May 21.
5
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.
N Engl J Med. 2012 Feb 23;366(8):697-706. doi: 10.1056/NEJMoa1108895.
6
Interval cancers after negative colonoscopy: population-based case-control study.
Gut. 2012 Nov;61(11):1576-82. doi: 10.1136/gutjnl-2011-301531. Epub 2011 Dec 26.
7
A review of factors that affect mortality following colectomy.
J Surg Res. 2012 May 15;174(2):192-9. doi: 10.1016/j.jss.2011.09.012. Epub 2011 Oct 6.
8
Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.
J Natl Cancer Inst. 2011 Sep 7;103(17):1310-22. doi: 10.1093/jnci/djr284. Epub 2011 Aug 18.
9
Risk factors for colonic and rectal cancer mortality: evidence from 40 years' follow-up in the Whitehall I study.
J Epidemiol Community Health. 2011 Nov;65(11):1053-8. doi: 10.1136/jech.2010.127555. Epub 2011 Mar 9.
10
Protection from colorectal cancer after colonoscopy: a population-based, case-control study.
Ann Intern Med. 2011 Jan 4;154(1):22-30. doi: 10.7326/0003-4819-154-1-201101040-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验